This article is more than 5 years old. Information may no longer be current.
Top infectious disease stories: Telehealth promotes antimicrobial stewardship in rural areas, range of H. capsulatum expanding in US
Among the top stories in infectious disease this week was a study that showed the feasibility of using telehealth to promote antimicrobial stewardship in nonurban locations and reports that the endemic range of Histoplasma capsulatum was expanding beyond the Mississippi and Ohio River basins where it was once most prevalent and that C. auris is emerging in New York.
Other top stories included a report that found the likely cause of the first nosocomial mcr-1 transmission in the United States and a study that concluded research into various vaccines is significantly underfunded. – by Janel Miller
Telehealth promotes antimicrobial stewardship in rural settings
Researchers tested the feasibility of using telehealth to promote antimicrobial stewardship at two rural Veterans Affairs medical centers with limited access to infectious disease specialists and found it to be feasible, according study results published in Infection Control & Hospital Epidemiology. Read more.
Report details ‘concerning’ emergence of C. auris in New York
Health care facilities in New York City are experiencing a large, citywide outbreak of Candida auris at multiple health facilities, according to findings published in Emerging Infectious Diseases. Read more.
Geographic range of H. capsulatum expands in US
The endemic range of Histoplasma capsulatum in the United States has spread into the upper Missouri River basin, with cases of histoplasmosis occurring as far north as Montana, researchers reported recently in Emerging Infectious Diseases. Read more.
Duodenoscopes
likely cause of first nosocomial
mcr-1
transmission in US
Duodenoscopes were the likely cause of the first nosocomial transmission of the mobile colistin resistance gene mcr-1 in the United States, researchers reported in Clinical Infectious Diseases. Read more.
Study finds vaccine pipeline grossly underfunded
Global spending on research into “game-changing” products like vaccines for hepatitis C virus, HIV, malaria and tuberculosis is underfunded by as much as $2.8 billion per year, researchers reported recently in Gates Open Research. Read more.